Clinical Trials Browser

Phase 4 × Congresses as Topic × 90 days × Clear all

NCT02366819 2026-03-30

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Phase 4 Suspended

Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms